Cargando…

Building a Parkinson-Network–Experiences from Germany

Parkinson’s disease is a complex neurodegenerative disease that can be best treated with a multi-disciplinary care approach. Building care networks has been shown as a useful tool to facilitate the integration of care services and improve outcomes for patients and care providers. However, experience...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Munster, Marlena, Tönges, Lars, Loewenbrück, Kai F., Warnecke, Tobias, Eggers, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563415/ https://www.ncbi.nlm.nih.gov/pubmed/32854328 http://dx.doi.org/10.3390/jcm9092743

Ejemplares similares

Structured Care and Self-Management Education for Persons with Parkinson’s Disease: Why the First Does Not Go without the Second—Systematic Review, Experiences and Implementation Concepts from Sweden and Germany
por: Tennigkeit, Jenny, et al.
Publicado: (2020)

Recommendations for Standards of Network Care for Patients with Parkinson’s Disease in Germany
por: Prell, Tino, et al.
Publicado: (2020)

Specialized Staff for the Care of People with Parkinson’s Disease in Germany: An Overview
por: Prell, Tino, et al.
Publicado: (2020)

Parkinson Network Eastern Saxony (PANOS): Reaching Consensus for a Regional Intersectoral Integrated Care Concept for Patients with Parkinson’s Disease in the Region of Eastern Saxony, Germany
por: Loewenbrück, Kai F., et al.
Publicado: (2020)

Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany
por: Richter, Daniel, et al.
Publicado: (2020)

Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Deriving Implications for Care Delivery in Parkinson’s Disease by Co-Diagnosing Caregivers as Invisible Patients
por: Thieken, Franziska, et al.
Publicado: (2021)

Safety perception in patients with advanced idiopathic Parkinson’s disease – a qualitative study
por: Pedrosa, Anna J., et al.
Publicado: (2023)

COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Short-chain fatty acids in the context of Parkinson’s disease
por: Metzdorf, Judith, et al.
Publicado: (2021)

Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson’s Disease
por: Tahmasian, Masoud, et al.
Publicado: (2015)

Resource Utilization of Patients with Parkinson’s Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study
por: Kruse, Christopher, et al.
Publicado: (2021)

Dynamics of Parkinson’s Disease Multimodal Complex Treatment in Germany from 2010–2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers
por: Richter, Daniel, et al.
Publicado: (2019)

Adenosin A (2A) Rezeptorantagonisten als Therapieoption beim idiopathischen Parkinson-Syndrom?
por: Jost, Wolfgang H., et al.
Publicado: (2022)

The default mode network and cognition in Parkinson's disease: A multimodal resting‐state network approach
por: Ruppert, Marina C., et al.
Publicado: (2021)

Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
por: Tönges, Lars, et al.
Publicado: (2022)

Measuring the Usability of eHealth Solutions for Patients With Parkinson Disease: Observational Study
por: Bendig, Jonas, et al.
Publicado: (2022)

Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
por: Steidel, Kenan, et al.
Publicado: (2022)

Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021
por: Richter, Daniel, et al.
Publicado: (2023)

Health-Related Quality of Life Subdomains in Patients with Parkinson's Disease: The Role of Gender
por: Ophey, Anja, et al.
Publicado: (2018)

Coping Styles in Patients with Parkinson’s Disease: Consideration in the Co-Designing of Integrated Care Concepts
por: Stümpel, Johanne, et al.
Publicado: (2022)

Measuring Quality of Life in Parkinson’s Disease—A Call to Rethink Conceptualizations and Assessments
por: Stührenberg, Maria, et al.
Publicado: (2022)

Telemedicine as an Untapped Opportunity for Parkinson’s Nurses Training in Personalized Care Approaches
por: van Munster, Marlena, et al.
Publicado: (2022)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
por: Roser, Anna-Elisa, et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on perceived access and quality of care in German people with parkinsonism
por: van Munster, Marlena, et al.
Publicado: (2023)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

Parkinson’s Disease Subtypes Show a Specific Link between Dopaminergic and Glucose Metabolism in the Striatum
por: Eggers, Carsten, et al.
Publicado: (2014)

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

The Role of Parkinson Nurses for Personalizing Care in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: van Munster, Marlena, et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Building on basic metagenomics with complementary technologies
por: Warnecke, Falk, et al.
Publicado: (2007)

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
por: Richter, Daniel, et al.
Publicado: (2018)

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022)

Seasonal Bordetella pertussis pattern in the period from 2008 to 2018 in Germany
por: Hitz, Daniel Allermann, et al.
Publicado: (2020)

Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson Nurses
por: van Munster, Marlena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cskh54b244b3l5tafd7vc874pk